New Perspectives on Antimicrobial Agents: Tecovirimat for Treatment of Human Monkeypox Virus

被引:42
作者
DeLaurentis, Clare E. [1 ]
Kiser, Jennifer [2 ]
Zucker, Jason [1 ]
机构
[1] Columbia Univ Med Ctr, Div Infect Dis, New York, NY 10032 USA
[2] Univ Colorado Anschutz Med Campus, Aurora, CO USA
基金
美国国家卫生研究院;
关键词
human monkeypox virus; TPOXX; tecovirimat; CLINICAL CHARACTERISTICS; ST-246; SMALLPOX; PHARMACOKINETICS; DISEASE; SAFETY;
D O I
10.1128/aac.01226-22
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Tecovirimat is an antiviral drug initially developed against variola virus (VARV) to treat smallpox infection. Due to its mechanism of action, it has activity against the family of orthopoxviruses, including vaccinia and the human monkeypox virus (HMPXV). Efficacy studies have thus far been limited to animal models, with human safety trials showing no serious adverse events. Currently approved by the FDA only for the treatment of smallpox, tecovirimat shows promise for the treatment of HMPXV. Tecovirimat has been prescribed via an expanded access for an investigational new drug protocol during the 2022 outbreak. This review will examine the literature surrounding tecovirimat's mechanism of action, pharmacokinetics, safety, efficacy, and potential for resistance.
引用
收藏
页数:8
相关论文
共 41 条
[1]   Clinical features and management of human monkeypox: a retrospective observational study in the UK [J].
Adler, Hugh ;
Gould, Susan ;
Hine, Paul ;
Snell, Luke B. ;
Wong, Waison ;
Houlihan, Catherine F. ;
Osborne, Jane C. ;
Rampling, Tommy ;
Beadsworth, Mike Bj ;
Duncan, Christopher Ja ;
Dunning, Jake ;
Fletcher, Tom E. ;
Hunter, Ewan R. ;
Jacobs, Michael ;
Khoo, Saye H. ;
Newsholme, William ;
Porter, David ;
Porter, Robert J. ;
Ratcliffe, Libuse ;
Schmid, Matthias L. ;
Semple, Malcolm G. ;
Tunbridge, Anne J. ;
Wingfield, Tom ;
Price, Nicholas M. .
LANCET INFECTIOUS DISEASES, 2022, 22 (08) :1153-1162
[2]   The changing epidemiology of human monkeypox-A potential threat? A systematic review [J].
Bunge, Eveline M. ;
Hoet, Bernard ;
Chen, Liddy ;
Lienert, Florian ;
Weidenthaler, Heinz ;
Baer, Lorraine R. ;
Steffen, Robert .
PLOS NEGLECTED TROPICAL DISEASES, 2022, 16 (02)
[3]  
Centers for Disease Control, 2023, BB-IND No. 10788
[4]  
CDC IRB No. 3744 Version 8.1
[5]  
Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P561
[6]   Benefit-risk assessment for brincidofovir for the treatment of smallpox: US Food and Drug Administration's Evaluation [J].
Chan-Tack, Kirk ;
Harrington, Patrick ;
Bensman, Timothy ;
Choi, Su-Young ;
Donaldson, Eric ;
O'Rear, Julian ;
McMillan, David ;
Myers, Laine ;
Seaton, Mark ;
Ghantous, Hanan ;
Cao, Yu ;
Valappil, Thamban ;
Birnkrant, Debra ;
Struble, Kimberly .
ANTIVIRAL RESEARCH, 2021, 195
[7]   Assessing a drug for an eradicated human disease: US Food and Drug Administration review of tecovirimat for the treatment of smallpox [J].
Chan-Tack, Kirk M. ;
Harrington, Patrick R. ;
Choi, Su-Young ;
Myers, Laine ;
O'Rear, Julian ;
Seo, Shirley ;
McMillan, David ;
Ghantous, Hanan ;
Birnkrant, Debra ;
Sherwat, Adam, I .
LANCET INFECTIOUS DISEASES, 2019, 19 (06) :E221-E224
[8]  
Chimerix, 2021, TEMBEXA PRESCR INF
[9]   Safety and Pharmacokinetics of the Anti-Orthopoxvirus Compound ST-246 following a Single Daily Oral Dose for 14 Days in Human Volunteers [J].
Chinsangaram, Jarasvech ;
Honeychurch, Kady M. ;
Tyavanagimatt, Shanthakumar R. ;
Leeds, Janet M. ;
Bolken, Tove' C. ;
Jones, Kevin F. ;
Jordan, Robert ;
Marbury, Thomas ;
Ruckle, Jon ;
Mee-Lee, Denis ;
Ross, Eric ;
Lichtenstein, Israel ;
Pickens, Margaret ;
Corrado, Michael ;
Clarke, Jean M. ;
Frimm, Annie M. ;
Hruby, Dennis E. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (09) :4900-4905
[10]   Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection [J].
Desai, Angel N. ;
Thompson, George R., III ;
Neumeister, Sonja M. ;
Arutyunova, Anna M. ;
Trigg, Katelyn ;
Cohen, Stuart H. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (13) :1348-1350